Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WATCHMAN FLX Pro European Registry

NCT07262255 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT07262255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WATCHMAN FLX Pro European Registry
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
December 17, 2025
Completion date
September 30, 2028
Enrollment
189 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

left atrial appendage closure, non-valvular atrial fibrillation (af)